BDL
RMD icon

Banque de Luxembourg’s ResMed RMD Stock Holding History

Banque de Luxembourg’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600
Closed -$164K – 91
2025
Q3 		$164K Sell
600
-917
-60% -$250K 0.08% 53
2025
Q2 		$340K Hold
1,517
– – 0.19% 38
2025
Q1 		$340K Sell
1,517
-160
-10% -$37.4K 0.19% 37
2024
Q4 		$385K Buy
+1,677
New +$404K 0.21% 37

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Banque de Luxembourg's RMD Position: Q4 2025 in Review

Banque de Luxembourg sold out of ResMed (RMD) in Q4 2025, closing a stake of 600 shares — an estimated $164K sold.

Banque de Luxembourg first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $385K in Q4 2024. 946 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Banque de Luxembourg reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Banque de Luxembourg sold 600 ResMed shares in Q4 2025, an estimated $164K.
  • Banque de Luxembourg first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Banque de Luxembourg's ResMed position peaked at $385K in Q4 2024.
  • 946 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Banque de Luxembourg's 13F filing for Q4 2025, filed 21 Jan 2026.